Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2008-04-21
2010-06-29
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S145100, C530S387100
Reexamination Certificate
active
07744873
ABSTRACT:
The present invention provides methods and kits for diagnosing and treating glaucoma.
REFERENCES:
patent: 5145871 (1992-09-01), Cavazza
patent: 5364884 (1994-11-01), Varma et al.
patent: 6207450 (2001-03-01), Sheffield et al.
patent: 6248571 (2001-06-01), Schmidt et al.
patent: 6248867 (2001-06-01), Nguyen et al.
patent: 6613563 (2003-09-01), Sosnowski et al.
patent: 9614411 (1996-05-01), None
patent: 9820889 (1998-05-01), None
patent: 0061774 (2000-10-01), None
patent: 0068247 (2000-11-01), None
patent: 0077021 (2000-12-01), None
patent: 02077006 (2002-10-01), None
patent: 02085909 (2002-10-01), None
Stabile et al., Blood, 109: 1834-1840, 2007.
Lappin et al., Nephrol. Dial. Transpl., 17 (Suppl): 65-67, 2002.
Agarwal et al., “Expression of Transforming Growth Factor Beta Isoforms (TGF-β 1-3) and Receptors (TGFβ RI-RIII) in Cultured Human Trabecular Meshwork Cells”, IOVS 38(4):S563 (1997).
Agarwal R, et al., “FAS-activated apoptosis and other apoptosis mediators in human trabecular meshwork cells,” Exp. Eye Res. 68:583-590 (1999.
Agarwal et al., “The Expression of Bone Morphogenetic Protein (BMP) and BMP Receptor mRNA by Human Trabecular Meshwork and Optic Nerve Head Cells and Tissues”, IOVS 41(4):S506 (2000).
Astrom, A.K., et al., “Chromosomal localization of three human genes encoding bone morphogenetic protein receptors”, Mammalian Genome 10(3):299-302 (1999).
Attisano L, Tuen Lee-Hoeflich S, “The Smads,” Genome Biol. 2(8) Reviews/3010.1 (2001) 1-8.
Bengtsson B, “Incidence of manifest glaucoma,” Br J Ophthalmol, 73:483-487 (1989).
Birren, et al., Genome Analysis, A Laboratory Manual vol. 2 Detecting Genes, (Bruce Birren ed., Cold Spring Harbor Laboratory Press 1998) 287-292.
Chang et al., “Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure”, BioMed Central, BMC Genetics, 2:18 (2001).
Chundru et al., “Detection of neurotrophins in human aqueous humor,” Invest. Ophthalmol. Vis. Sci. 41(4):S326 (2000).
Clark AF, et al., “Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells,” Invest. Ophthalmol. & Vis. Sci. 35(1):281-294 (1994).
Clark AF, et al., “Cell biology of the human lamina cribrosa,” In Drance SM (ed). Optic Nerve in Glaucoma. Kugler Publications, New York: pp. 79-105 (1995).
Clark AF, et al., “Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells,” J. Glaucoma 4:183-188 (1995).
Clark AF, et al., “Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes,” Invest. Ophthalmol. & Vis. Sci. 36(2):478-489 (1995).
Clark AF, et al., “Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol,” Invest. Ophthalmol. & Vis. Sci. 37(5):805-813 (1996).
Clark AF, et al., “Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head,” FASEB J. 15:1251-1253 (2001).
Clark AF, et al., “Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues,” Invest. Ophthalmol. & Vis. Sci. 42(8):1769-1780 (2001).
Cummings, Michael R., Human Heredity, Fourth Edition, (West/Wadsworth 1997) 266-283.
Dickerson JE, et al., “The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells,” Exp. Eye Res. 66:731-738 (1998).
Dudley et al., “A requirement for bone morphogenic protein-7 during development of the mammalian kidney and eye,” Genes & Development 9:2795-2807 (1995).
Elbashir SM, et al., “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”, Nature 411:494-498, 2001.
Encio et al., “The Genomic Structure of the Human Glucocorticoid Receptor”, J. Biol. Chem. 266(11):7182-7188 (1991).
Furuta and Hogan, “BMP4 is essential for lens induction in the mouse embryo,” Genes & Dev. 12:3764-3775 (1998).
Giguère et al., “Functional Domains of the Human Glucocorticoid Receptor”, Cell 46:645-652 (1986).
Greve, M. et al., “Comparison of the oculokinetic perimetry glaucoma screener with two types of visual filed analyser”, Can. J. Ophthamol. 28(5):201-206 (1993).
Grierson I et al., “Characteristics of Meshwork Cells and Age Changes in the Outflow System of the Eye: Their Relevance to Primary Open Angle Glaucoma.” In Mills KB (ed). Glaucoma. Proceedings of the Fourth International Symposium of the Northern Eye Institute, Manchester, UK, New York, Pergamon: pp. 12-31 (1988).
Gutteridge, “Normal tension glaucoma: diagnostic features and comparison with primary open angle glaucoma”; Clinical and Exp. Optometry; 83: 161-172 (2000).
Hernandez M and Gong H, “Extracellular matrix of the trabecular meshwork and optic nerve head.” in Ritch R., Shields, M.B., Krupin, T. (eds). The Glaucomas, 2nd ed. St Louis: Mosby-Year; pp. 213-249 (1996).
Hernandez, et al., “Changes in the Extracellular Matrix of the Human Optic Nerve Head in Primary Open-Angle Glaucoma,” Am. J. Ophthalmol. 109:180-188 (1990).
Hernandez MR and Pena JD, “The optic nerve head in glaucomatous optic neuropathy,” Arch Ophthalmol. 115:389-395 (1997).
Hitchings RA, “Glaucoma screening”, Br. J. Ophthamol. 77:326 (1993).
Jain, R.; “Vascular and interstitial barriers to delivery of therapeutic agents in tumors”; Cancer and Metastasis Reviews; 9; 253-266 (1990).
Liu X., et al.; Human trabecular meshwork cells express the ciliary neurotrophic factor (CNTF) tripartate receptor complex; Exp. Eye Res.; 72:711-717 (2001).
Hogan BL, “Bone morphogenic proteins: multifunctional regulators of vertebrate development,” Genes Dev. 10:1580-1594 (1996).
Hollenberg et al., “Primary Structure and Expression of a Functional Human Glucocorticoid Receptor cDNA”, Nature 318(19):635-641 (1985).
Hu and Ritch, “Hepatocyte Growth Factor is Increased in the Aqueous Humor of Glaucomatous Eyes,” J. Glaucoma 10:152-157 (2001).
Inatani et al., “Transforming growth factor β2 levels in aqueous humor of glaucomatous eyes,” Graefes Arch. Clin. Exp. Ophthalmol. 239:109-113 (2001).
Itoh et al., “Signaling of transforming growth factor-β family members through Smad proteins”, Eur. J. Biochem. 267:6954-6967 (2000).
Jacobson N, et al., “Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor,” Human Molecular Genetics 10(2):117-125 (2001).
Jena et al., “BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye,” Exp. Cell Res. 230:28-37 (1997).
Jorde, et al., Medical Genetics, Second Edition, (Mosby 1999) 29-57.
Kawabata et al., “Signal Transduction by Bone Morphogenetic Proteins”, Cytokine & Growth Factor Reviews, vol. 9, No. 1, 49-61 (1998).
Kerrigan et al., “TUNEL-positive ganglion cells in human primary open-angle glaucoma,” Arch. Ophthalmol. 115:1031-1035 (1997).
Lambert et al., “Expression of TGF-Beta Isoforms and Their Receptor mRNA'S in Cultured Human Lamina Cribrosa Cells”, IOVS 38(4):S162 (1997).
Lambert, et al. “Map Kinase Activation and Cell Proliferation of Cultured Lamina Cribrosa Cells Following Exogenous NGF Treatment”, IOVS 41(4):S827 (2000).
Lambert W, et al., “Neurotrophin and neurotrophin receptor expression by cells from the human lamina cribrosa,” Invest. Ophthalmol. Vis. Sci., 42(10):2315-2323 (2001).
Leske MC, et al., “The Epidemiology of Open-Angle Glaucoma: A Review”, American Journal of Epidemilogy, 118 (2):166-191 (1983).
Liu et al., “Expression of Ciliary Neurotrophic Factor (CNTF), Glial Derive
Clark Abbot F.
Wordinger Robert J.
Alcon Inc.
Chandra Gyan
Derry Jason J.
Landsman Robert
University of North Texas Health Science Center
LandOfFree
Method for treating glaucoma comprising administering to a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating glaucoma comprising administering to a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating glaucoma comprising administering to a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218184